Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Number of holders
-
279
-
Total 13F shares, excl. options
-
96,763,330
-
Shares change
-
+4,272,249
-
Total reported value, excl. options
-
$9,041,659,322
-
Value change
-
+$427,442,108
-
Put/Call ratio
-
57%
-
Number of buys
-
138
-
Number of sells
-
113
-
Price
-
$93.45
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2019
As of 31 Mar 2019 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 96,763,330 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, DODGE & COX, PRICE T ROWE ASSOCIATES INC /MD/, MAVERICK CAPITAL LTD, STATE STREET CORP, and BB BIOTECH AG.
This table shows 279 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.